Latecomers' catch-up strategy in biopharmaceutical industry : case of Korea후발국의 바이오제약산업 추격 전략 : 한국 사례를 중심으로

Cited 0 time in webofscience Cited 0 time in scopus
  • Hit : 186
  • Download : 0
Korean biopharmaceutical firms, the latecomers in a long-cycle industry, are producing innovative outcomes of developing and out-licensing new drug candidates. It challenges the notion that latecomers achieve catch-up mostly the industries with shorter technology cycle. This thesis aims to explore the phenomenon and illustrates the latecomers’ catch-up and innovation strategies in the biopharmaceutical industry. To achieve the research purpose, this research poses the following question: How can the latecomer firms achieve innovation in the biopharmaceutical industry? The research examines the case of the Korean biopharmaceutical industry with a sectoral system of innovation perspective. Three empirical analyses explore the key characteristics of learning in knowledge and technologies, actors and their networks, and institutional design. The findings show that Korean biopharmaceutical firms have built technology capabilities in the area of clinical research. The intensity of clinical research has a positive effect on the learning curve and out-licensing performances. The analyses also show that Korean biopharmaceutical firms have leveraged domestic hospitals to acquire the requisite knowledge. As for the knowledge utilisation network, the firms use final product knowledge via international collaboration while utilising a domestic network to acquire knowledge of research in progress and collaborate for new product development. Lastly, the analyses also illuminate that institutional design is a critical factor. The sequential implementation of patent and clinical trial policies positively affects the innovation process. These findings are contrasting from multinational pharmaceutical innovation studies which highlight the basic research capability leveraging the network with foreign universities and the simple introduction of patent regulations. This research makes contributions in three aspects. First, it makes a theoretical contribution by suggesting the possibility that latecomers can catch up in a long-cycle industry. Second, it provides strategic direction for latecomer biopharmaceutical firms to leverage local infrastructure rather than use the follower strategy. Third, it has a technology policy implication that priority setting is important for promoting domestic industry development.
Advisors
Choung, Jae-Yongresearcher정재용researcher
Description
한국과학기술원 :기술경영학부,
Publisher
한국과학기술원
Issue Date
2020
Identifier
325007
Language
eng
Description

학위논문(박사) - 한국과학기술원 : 기술경영학부, 2020.2,[v, 238 p. :]

Keywords

catch-up strategy▼alatecomer▼abiopharmaceutical▼anew drug development▼aknowledge utilization▼anetwork▼apolicy; 추격 전략▼a후발국▼a바이오제약▼a신약개발▼a기술활용▼a네트워크▼a정책

URI
http://hdl.handle.net/10203/284091
Link
http://library.kaist.ac.kr/search/detail/view.do?bibCtrlNo=908477&flag=dissertation
Appears in Collection
MG-Theses_Ph.D.(박사논문)
Files in This Item
There are no files associated with this item.

qr_code

  • mendeley

    citeulike


rss_1.0 rss_2.0 atom_1.0